FX Solutions [FX Shoulder, Inc.] Receives FDA 510k Clearances for TiN Coated Humeral Heads and Glenospheres

Xenter, Inc. Appoints 4 Industry Leaders to Board of Directors; Closes $12M Series A

Xenter’s first product, which the company will announce shortly, is a medical device that not only combines the function of multiple existing devices but will also revolutionize the field of interventional medicine by producing valuable Physical Intelligence™ data and enabling advanced Artificial Intelligence solutions, leading to improved patient outcomes while reducing the cost, complexity and invasiveness of cardiac procedures.

Indivumed Partners with Oslo University Hospital to Advance Cancer Research

By scanning high-resolution images of haematoxylin and eosin-stained tumor section slides for all IndivuType cases, Indivumed will be able to leverage an entirely new dimension of data in the coming months.

Harold Hill Joins NeuX Technologies as Director of Corporate Accounts

Harold Hill is a retired Special Forces Medic, serving 26 years, and led the medical department for a Special Missions Unit within the United States Special Operations Command

TiN Coated Humeral Heads and Glenospheres: FX received 510k clearances for their TiN (Titanium Nitride) Coated Humeral Heads and Glenospheres. The new addition of TiN coated humeral heads and glenospheres adds unique-to-market prostheses to the FX portfolio.

The TiN coated humeral heads and glenospheres are identical to the current humeral heads and glenospheres that we offer but with the TiN coating applied. The TiN coated humeral head is compatible with the Humelock II and Humeris shoulder in the anatomic construct while the TiN coated glenosphere is compatible with the Humelock II®, Humelock Reversed®, and Humeris® shoulder systems in the reverse (or reversible) construct.

Wear testing under worst case load and worst-case environment demonstrated substantial equivalence with the uncoated current CoCr (Cobalt Chromium) products. Other characteristics tested demonstrated no difference in results for those with TiN coating compared to the uncoated product, and there were no TiN particles detected in the analyzed test fluids. FX does not make any claims about the use of these TiN products for patients with nickel allergies.

“We are now able to reach a broad market and provide surgeons even more shoulder arthroplasty solutions to address patients’ needs. As we continue to expand our portfolio, we truly have one of the more comprehensive portfolios dedicated exclusively to shoulder arthroplasty,” said Baptiste Martin, CEO of FX Shoulder USA.

spot_img

DON'T MISS

Subscribe to Medical Device News Magazine

Related Articles